Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2019 01:03 ET | Source: ORPHAZYME A/S

Orphazyme announces Interim Report First Half 2019

Company announcement Orphazyme A/SNo....
August 27, 2019 15:14 ET | Source: ORPHAZYME A/S

Orphazyme strengthens balance sheet with EUR 9 million financing from Kreos Capital

Company announcement Orphazyme A/SNo. 25/2019 Company Registration No. 32266355 Loan agreement to...
August 21, 2019 06:23 ET | Source: ORPHAZYME A/S

Orphazyme Interim Report First Half 2019 Presentation

Investor news Orphazyme A/SCompany Registration No. 32266355 Copenhagen, Denmark, August...
August 05, 2019 12:20 ET | Source: ORPHAZYME A/S

Major shareholder announcement

Company announcement No. 24/2019 Orphazyme...
July 29, 2019 14:18 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No....
July 29, 2019 11:19 ET | Source: ORPHAZYME A/S

New phantom share-based incentive program

Orphazyme A/SCompany announcement No. 22/2019 ...
July 29, 2019 11:16 ET | Source: ORPHAZYME A/S

New share-based incentive program

Orphazyme A/SCompany announcement No. 21/2019 ...
July 29, 2019 11:11 ET | Source: ORPHAZYME A/S

New incentive program for the Board of Directors of Orphazyme

Orphazyme A/SCompany announcement No. 20/2019 Company Registration No. 32266355 ...
July 26, 2019 10:35 ET | Source: ORPHAZYME A/S

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement No. 19/2019Company Registration No. 32266355 ...
July 21, 2019 06:03 ET | Source: ORPHAZYME A/S

Orphazyme to prepare for filing of arimoclomol in US for Niemann-Pick disease Type C (NPC)

Orphazyme A/SCompany announcement No. 18/2019Company Registration No. 32266355 ...